ExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Services
SectorN/A
SymbolNYSE:EXAM
CUSIP30066A10
Phone+1-404-9522400
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins1.44%
Return on Equity3.60%
Return on Assets1.21%
Miscellaneous
EmployeesN/A
Outstanding Shares41,240,000
Examworks Group (NYSE:EXAM) Frequently Asked Questions
What is Examworks Group's stock symbol?
Examworks Group trades on the New York Stock Exchange (NYSE) under the ticker symbol "EXAM."
How were Examworks Group's earnings last quarter?
Examworks Group, Inc. (NYSE:EXAM) announced its earnings results on Tuesday, May, 10th. The business services provider reported $0.08 EPS for the quarter, hitting the Zacks' consensus estimate of $0.08. The business services provider had revenue of $226.50 million for the quarter, compared to analysts' expectations of $217.47 million. Examworks Group had a return on equity of 3.60% and a net margin of 1.44%. Examworks Group's revenue for the quarter was up 15.4% compared to the same quarter last year. During the same period last year, the firm earned $0.05 EPS. View Examworks Group's Earnings History.
Has Examworks Group been receiving favorable news coverage?
Media coverage about EXAM stock has trended somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Examworks Group earned a coverage optimism score of 0.16 on Accern's scale. They also assigned media coverage about the business services provider an impact score of 46.66 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Examworks Group?
Shares of EXAM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Examworks Group's stock price today?
One share of EXAM stock can currently be purchased for approximately $35.06.
How big of a company is Examworks Group?
Examworks Group has a market capitalization of $1.46 billion.
How can I contact Examworks Group?
Examworks Group's mailing address is 3280 Peachtree Rd NE Ste 2625, ATLANTA, GA 30305-2457, United States. The business services provider can be reached via phone at +1-404-9522400.
MarketBeat Community Rating for Examworks Group (EXAM)
MarketBeat's community ratings are surveys of what our community members think about Examworks Group and other stocks. Vote "Outperform" if you believe EXAM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXAM will underperform the S&P 500 over the long term. You may vote once every thirty days.
